Nothing Special   »   [go: up one dir, main page]

You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.
 
 
Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Article Types

Countries / Regions

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Search Results (3,274)

Search Parameters:
Keywords = ultrasound imaging

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
15 pages, 6196 KiB  
Article
Image-Guided Radiation Therapy Is Equally Effective for Basal and Squamous Cell Carcinoma
by Erin M. McClure, Clay J. Cockerell, Stephen Hammond, Evelyn S. Marienberg, Bobby N. Koneru, Jon Ward and Jeffrey B. Stricker
Dermatopathology 2024, 11(4), 315-329; https://doi.org/10.3390/dermatopathology11040033 (registering DOI) - 19 Nov 2024
Abstract
Non-melanoma skin cancers (NMSCs), including basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), are highly prevalent and a significant cause of morbidity. Image-guided superficial radiation therapy (IGSRT) uses integrated high-resolution dermal ultrasound to improve lesion visualization, but it is unknown whether efficacy [...] Read more.
Non-melanoma skin cancers (NMSCs), including basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), are highly prevalent and a significant cause of morbidity. Image-guided superficial radiation therapy (IGSRT) uses integrated high-resolution dermal ultrasound to improve lesion visualization, but it is unknown whether efficacy varies by histology. This large retrospective cohort study was conducted to determine the effect of tumor histology on freedom from recurrence in 20,069 biopsy-proven NMSC lesions treated with IGSRT, including 9928 BCCs (49.5%), 5294 SCCs (26.4%), 4648 SCCIS cases (23.2%), and 199 lesions with ≥2 NMSCs (1.0%). Freedom from recurrence at 2, 4, and 6 years was 99.60%, 99.45%, and 99.45% in BCC; 99.58%, 99.49%, and 99.49% in SCC; and 99.96%, 99.80%, and 99.80% in SCCIS. Freedom from recurrence at 2, 4, and 6 years following IGSRT did not differ significantly comparing BCC vs. non-BCC or SCC vs. non-SCC but were slightly lower among SCCIS vs. non-SCCIS (p = 0.002). There were no significant differences in freedom from recurrence when stratifying lesions by histologic subtype. This study demonstrates that there is no significant effect of histology on freedom from recurrence in IGSRT-treated NMSC except in SCCIS. These findings support IGSRT as a first-line therapeutic option for NMSC regardless of histology. Full article
Show Figures

Figure 1

Figure 1
<p>Histological examples of nodular BCC (<b>A</b>), superficial BCC (<b>B</b>), squamous differentiation BCC (<b>C</b>), infiltrative (<b>D</b>), and morpheaform BCC (<b>E</b>).</p>
Full article ">Figure 2
<p>Histological examples of SCCIS (<b>A</b>) and well-differentiated SCC (<b>B</b>).</p>
Full article ">Figure 3
<p>Freedom from recurrence over time of non-melanoma skin cancers treated with image-guided superficial radiation therapy in patients with basal cell carcinoma versus non-basal cell carcinoma skin cancers.</p>
Full article ">Figure 4
<p>Freedom from recurrence over time of non-melanoma skin cancers treated with image-guided superficial radiation therapy in patients with squamous cell carcinoma versus non-squamous cell carcinoma skin cancers.</p>
Full article ">Figure 5
<p>Freedom from recurrence over time of non-melanoma skin cancers treated with image-guided superficial radiation therapy in patients with squamous cell carcinoma in situ versus non-squamous cell carcinoma in situ skin cancers.</p>
Full article ">Figure 6
<p>Freedom from recurrence over time of basal cell carcinoma subtypes treated with image-guided superficial radiation therapy.</p>
Full article ">Figure 7
<p>Freedom from recurrence over time of well-differentiated squamous cell carcinoma treated with image-guided superficial radiation therapy.</p>
Full article ">Figure 8
<p>Case 1. Complete response of nodular basal cell carcinoma to IGSRT. Top panels demonstrate the ultrasound images of the IGSRT device before treatment (simulation), mid-treatment, and at final follow-up. The bottom panels demonstrate the clinical response at these same time points.</p>
Full article ">Figure 9
<p>Case 2. Complete response of squamous cell carcinoma to IGSRT. Top panels demonstrate the ultrasound images of the IGSRT device before treatment (simulation), mid-treatment, and at final follow-up. The bottom panels demonstrate the clinical response at these same time points.</p>
Full article ">Figure 10
<p>Recurrence of nodular basal cell carcinoma after IGSRT treatment. Top panels demonstrate the ultrasound images of the IGSRT device before treatment (simulation), mid treatment, and at final follow-up. The bottom panels demonstrate the clinical response at these same time points.</p>
Full article ">
17 pages, 31067 KiB  
Article
Feasibility of Non-Invasive Sentinel Lymph Node Identification in Early-Stage NSCLC Through Ultrasound Guided Intra-Tumoral Injection of 99mTc-Nanocolloid and Iodinated Contrast Agent During Navigation Bronchoscopy
by Desi K. M. ter Woerds, Roel L. J. Verhoeven, Erik H. J. G. Aarntzen and Erik H. F. M. van der Heijden
Cancers 2024, 16(22), 3868; https://doi.org/10.3390/cancers16223868 - 19 Nov 2024
Viewed by 67
Abstract
Background: As the first sentinel lymph nodes (SLN) in lung cancer are most likely to harbor metastasis, their non-invasive identification could have a significant role in future treatments. We investigated the feasibility of adding an SLN procedure to a diagnostic navigation bronchoscopy. [...] Read more.
Background: As the first sentinel lymph nodes (SLN) in lung cancer are most likely to harbor metastasis, their non-invasive identification could have a significant role in future treatments. We investigated the feasibility of adding an SLN procedure to a diagnostic navigation bronchoscopy. Methods: Thirty-one patients were included for injection of 99mTc-nanocolloid and an iodinated contrast agent intra-/peritumorally and assessment of tracer dissipation via SPECT and CBCT imaging. Injections were performed endobronchially using a multi-modal catheter (Pioneer Plus), combining radial ultrasound and an angulated retractable needle to place injections under fluoroscopy and real-time ultrasound. Results: The injection of an imaging tracer was feasible in all cases using the catheter. Ultrasound visualized 29/30 tumors, and tracer injection was performed in 100% of patients. An SLN was subsequently identified in 10 out of 31 cases (32.3%) via SPECT/CT imaging. Iodinated contrast agent injection under CBCT imaging prior to 99mTc nanocolloid injection visualized dissipation pathways and enabled needle relocation for subsequent 99mTc-nanocolloid injection. Conclusions: Performing imaging tracer injections with a multi-modal catheter provided safe and local depot placement immediately following diagnostic navigation bronchoscopy. SPECT/CT imaging using 99mTc-nanocolloid showed inconsistent results for SLN identification. Full article
(This article belongs to the Special Issue Clinical Applications of Ultrasound in Cancer Imaging and Treatment)
Show Figures

Figure 1

Figure 1
<p>Visualization of the Pioneer Plus catheter in patient (<b>A</b>) with a view of the radial US image (<b>B</b>) and augmented fluoroscopy (<b>C</b>) in a suite equipped with a Philips Azurion Flexarm CBCT system. Augmented fluoroscopy depicts two parts of the lesion in dark and light blue and a pink dot for the catheter position on CBCT, used for navigation and sampling. The US transducer (distal) and needle shaft (proximal) can be seen as radiopaque in (<b>C</b>). Abbreviations: CBCT, cone beam computed tomography; US, ultrasound.</p>
Full article ">Figure 2
<p>Visualization of a solid lesion (<b>A</b>), part-solid lesion (<b>B</b>), and GGO (<b>C</b>) on radial US imaging via the Pioneer Plus catheter after having completed diagnostic navigation bronchoscopy, pre-injection. (<b>A</b>) The solid lesion is clearly visualized. Beyond the lesion, some intra-parenchymal bleeding following previous sampling altered the echogenicity of the lung parenchyma. (<b>B</b>) The part-solid lesion is visualized, along with the GGO component that can be predominantly seen from 9 to 12 o’clock. Some hyper-echoic speckle is seen at the 4 to 7 o’clock position, following minor bleeding after biopsy. (<b>C</b>) The image of the GGO not only shows a mixed blizzard sign (as mentioned by Park et al. [<a href="#B23-cancers-16-03868" class="html-bibr">23</a>]) but also a clear (pulsating) vessel from the 6 to 9 o’clock position. The vessel should be out of the vicinity of the needle at the 12 o’clock position and should therefore stay in the 3 to 9 o’clock position during injection. Abbreviations: GGO, ground-glass opacity; US, ultrasound.</p>
Full article ">Figure 3
<p>Visualization of the <sup>99m</sup>Tc-nanocolloid detection in the coronal plane (upper left) and combined SPECT and low-dose CT images in the sagittal (upper right), transversal (lower left) and coronal plane (lower right) in one patient with an early scan time of 02:09 h (<b>A</b>) and a late scan time of 04:09 h (<b>B</b>). The SLN is visible in both scans, although more of the <sup>99m</sup>Tc-nanocolloid seems to have drained to the lymph node in the late scan.</p>
Full article ">Figure A1
<p>Visualization of the Pioneer Plus catheter near the lesion on AF with the needle in sheath (<b>A</b>), the needle deployed (<b>B</b>), and the catheter moved more distal to push the needle further into the tissue to enhance angulation (<b>C</b>). The needle sheath and US transducer appear to be radiopaque, while the needle is (minimally) radiopaque. A peritumoral injection was performed here. A red line is added for reference to indicate the needle position. The blue outline is the lesion as marked by AF on CBCT imaging, as is the purple dot that is used for reference during navigation. Abbreviations: AF, augmented fluoroscopy; US, ultrasound.</p>
Full article ">Figure A2
<p>Visualization of the Pioneer Plus catheter on CBCT imaging in the transversal plane (<b>A</b>), coronal plane (<b>B</b>), and adjusted planes (<b>C</b>). The needle visibly protrudes into the lesion in (<b>A</b>) and (<b>C</b>) (lower right) at the ten o’clock position of the radial US transducer. An intratumoral injection was performed here. The blue outline is the lesion as marked by AF on CBCT imaging, as is the purple dot that is used for reference during navigation. Abbreviations: AF, augmented fluoroscopy; CBCT, cone beam computed tomography; US, ultrasound.</p>
Full article ">Figure A3
<p>Visualization of an Iomeron injection, during injection (<b>A</b>), right after injection (<b>B</b>), and 2 min after injection (<b>C</b>). A depot of Iomeron 300 is slowly formed and also partially washes out within 2 min. The blue outline is the lesion as marked by AF on CBCT imaging, as are the purple dots that are used for reference during navigation. Abbreviations: AF, augmented fluoroscopy; CBCT, cone beam computed tomography.</p>
Full article ">Figure A4
<p>Visualization of the visibility of Iomeron 300 before injection (CBCT scan), directly after injection on a CBCT scan, and after 05:25 h on a low-dose CT scan. We can clearly see the dissipation of Iomeron 300 in the first scan, and at a later scan time, the contrast agent as almost completely dissolved. The blue outline is the lesion as marked by AF on CBCT imaging, as are the purple dots that are used for reference during navigation. Abbreviations: AF, augmented fluoroscopy; CBCT, cone beam computed tomography.</p>
Full article ">Figure A5
<p>Flowchart of study procedures, interim analysis, and adjustment performed to reduce patient burden and increase knowledge regarding injection dissipation and SLN identification.</p>
Full article ">
8 pages, 543 KiB  
Technical Note
Comprehensive Diagnostic Approach to Head and Neck Masses
by Raisa Chowdhury, Sena Turkdogan, Raihanah Alsayegh, Hamad Almhanedi, Dana Al Majid, Gabriella Le Blanc, George Gerardis and Lamiae Himdi
J. Otorhinolaryngol. Hear. Balance Med. 2024, 5(2), 17; https://doi.org/10.3390/ohbm5020017 - 19 Nov 2024
Viewed by 73
Abstract
Head and neck masses are a significant diagnostic challenge and differential diagnoses range from inflammatory, infectious, and neoplastic conditions. Timely, accurate evaluation is essential for optimal patient outcomes. This review highlights a systematic approach to diagnosing head and neck masses through comprehensive history, [...] Read more.
Head and neck masses are a significant diagnostic challenge and differential diagnoses range from inflammatory, infectious, and neoplastic conditions. Timely, accurate evaluation is essential for optimal patient outcomes. This review highlights a systematic approach to diagnosing head and neck masses through comprehensive history, physical examination, and a variety of diagnostic tools. Imaging modalities such as computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound are integral in diagnosis. Fine-needle aspiration (FNA) biopsy is a minimally invasive option for a preliminary diagnosis. However, in cases where it may be inconclusive or when extensive tissue sampling is needed to confirm a diagnosis, open tissue biopsy is considered. Collaboration among a multidisciplinary team (surgeons, radiologists, and pathologists) is vital in developing an effective individualized treatment plan. Early detection and accurate diagnosis of head and neck masses are critical for achieving favorable clinical outcomes. Full article
Show Figures

Figure 1

Figure 1
<p>Flowchart for the assessment of adults with a head and neck mass. A diagram illustrating the sequence of clinical evaluation and diagnostic procedures. CT: computed tomography; FNA: fine-needle aspiration. Adapted from the American Academy of Otolaryngology [<a href="#B1-ohbm-05-00017" class="html-bibr">1</a>].</p>
Full article ">
22 pages, 5326 KiB  
Article
Improving the Theranostic Potential of Magnetic Nanoparticles by Coating with Natural Rubber Latex for Ultrasound, Photoacoustic Imaging, and Magnetic Hyperthermia: An In Vitro Study
by Thiago T. Vicente, Saeideh Arsalani, Mateus S. Quiel, Guilherme S. P. Fernandes, Keteryne R. da Silva, Sandra Y. Fukada, Alexandre J. Gualdi, Éder J. Guidelli, Oswaldo Baffa, Antônio A. O. Carneiro, Ana Paula Ramos and Theo Z. Pavan
Pharmaceutics 2024, 16(11), 1474; https://doi.org/10.3390/pharmaceutics16111474 - 19 Nov 2024
Viewed by 96
Abstract
Background/Objectives: Magnetic nanoparticles (MNPs) have gained attention in theranostics for their ability to combine diagnostic imaging and therapeutic capabilities in a single platform, enhancing targeted treatment and monitoring. Surface coatings are essential for stabilizing MNPs, improving biocompatibility, and preventing oxidation that could compromise [...] Read more.
Background/Objectives: Magnetic nanoparticles (MNPs) have gained attention in theranostics for their ability to combine diagnostic imaging and therapeutic capabilities in a single platform, enhancing targeted treatment and monitoring. Surface coatings are essential for stabilizing MNPs, improving biocompatibility, and preventing oxidation that could compromise their functionality. Natural rubber latex (NRL) offers a promising coating alternative due to its biocompatibility and stability-enhancing properties. While NRL-coated MNPs have shown potential in applications such as magnetic resonance imaging, their effectiveness in theranostics, particularly magnetic hyperthermia (MH) and photoacoustic imaging (PAI), remains underexplored. Methods: In this study, iron oxide nanoparticles were synthesized via coprecipitation, using NRL as the coating agent. The samples were labeled by NRL amount used during synthesis: NRL-100 for 100 μL and NRL-400 for 400 μL. Results: Characterization results showed that NRL-100 and NRL-400 samples exhibited improved stability with zeta potentials of −27 mV and −30 mV, respectively and higher saturation magnetization values of 79 emu/g and 88 emu/g of Fe3O4. Building on these findings, we evaluated the performance of these nanoparticles in biomedical applications, including magnetomotive ultrasound (MMUS), PAI, and MH. NRL-100 and NRL-400 samples showed greater displacements and higher contrast in MMUS than uncoated samples (5, 8, and 9 µm) at 0.5 wt%. In addition, NRL-coated samples demonstrated an improved signal-to-noise ratio (SNR) in PAI. SNR values were 24.72 (0.51), 31.44 (0.44), and 33.81 (0.46) dB for the phantoms containing uncoated MNPs, NRL-100, and NRL-400, respectively. Calorimetric measurements for MH confirmed the potential of NRL-coated MNPs as efficient heat-generating agents, showing values of 43 and 40 W/g for NRL-100 and NRL-400, respectively. Conclusions: Overall, NRL-coated MNPs showed great promise as contrast agents in MMUS and PAI imaging, as well as in MH applications. Full article
(This article belongs to the Special Issue Recent Advances in Biomedical Applications of Magnetic Nanomaterials)
Show Figures

Figure 1

Figure 1
<p>(<b>a</b>) Schematic representation of the experimental setup for MMUS imaging experiments. (<b>b</b>) Schematic representation of the PAI system using the Nd:YAG laser as the excitation source and the ultrasound imaging system to acquire the data.</p>
Full article ">Figure 2
<p>Diffraction patterns of uncoated and coated MNPs with different amounts of NRL. The crystallite size (d) was determined using the Rietveld method.</p>
Full article ">Figure 3
<p>TEM images and histograms of the particle size distribution of uncoated MNPs (<b>a</b>,<b>b</b>), NRL-100 (<b>c</b>,<b>d</b>), and NRL-400 (<b>e</b>,<b>f</b>). Scale bar corresponds to 200 nm.</p>
Full article ">Figure 4
<p>ATR spectra of NRL, uncoated MNPs, and MNPs coated with different amounts of NRL.</p>
Full article ">Figure 5
<p>UV-Vi’s spectra of NRL, uncoated MNPs, and MNPs coated with different amounts of NRL.</p>
Full article ">Figure 6
<p>Magnetization curves after subtraction of the NRL mass from uncoated MNPs and MNPs coated with different amounts of NRL.</p>
Full article ">Figure 7
<p>Cell viability of B16-F10 cells after incubation for (<b>a</b>) 24 h and (<b>b</b>) 48 h with varying concentrations of NPs.</p>
Full article ">Figure 8
<p>(<b>a</b>) B-Mode and MMUS image of the phantom containing (<b>b</b>) uncoated MNPs, (<b>c</b>) NRL-100, and (<b>d</b>) NRL-400.</p>
Full article ">Figure 9
<p>Average induced displacements within the inclusions for phantoms containing different concentrations of the produced NPs.</p>
Full article ">Figure 10
<p>Magnetophoretic curves obtained for MNPs, NRL-100, and NRL-400.</p>
Full article ">Figure 11
<p>(<b>a</b>) Typical B-Mode image of a phantom. PA images at 750 nm of phantoms containing (<b>b</b>) uncoated MNPs, (<b>c</b>) NRL-100, and (<b>d</b>) NRL-400.</p>
Full article ">Figure 12
<p>Temperature variation as a function of time for the samples produced.</p>
Full article ">Figure 13
<p>(<b>a</b>) The SLP<sub>OW</sub> values of the samples at different concentrations by wt.% of NPs considering the overall weight of the coated MNPs, which includes both the MNPs core and the outer coating material, and (<b>b</b>) the SLP<sub>IO</sub> values measured as a function of TGA-corrected weight concentrations for the produced nanoparticles, focusing exclusively on the nanoparticle core.</p>
Full article ">
14 pages, 4918 KiB  
Article
Artificial Intelligence and Image Analysis-Assisted Diagnosis for Fibrosis Stage of Metabolic Dysfunction-Associated Steatotic Liver Disease Using Ultrasonography: A Pilot Study
by Itsuki Fujii, Naoki Matsumoto, Masahiro Ogawa, Aya Konishi, Masahiro Kaneko, Yukinobu Watanabe, Ryota Masuzaki, Hirofumi Kogure, Norihiro Koizumi and Masahiko Sugitani
Diagnostics 2024, 14(22), 2585; https://doi.org/10.3390/diagnostics14222585 - 18 Nov 2024
Viewed by 374
Abstract
Purpose: Elastography increased the diagnostic accuracy of liver fibrosis. However, several challenges persist, including the widespread utilization of equipment, difficulties in measuring certain cases, and the influence of viscosity factors. A rough surface and a blunted hepatic margin have long been acknowledged as [...] Read more.
Purpose: Elastography increased the diagnostic accuracy of liver fibrosis. However, several challenges persist, including the widespread utilization of equipment, difficulties in measuring certain cases, and the influence of viscosity factors. A rough surface and a blunted hepatic margin have long been acknowledged as valuable characteristics indicative of hepatic fibrosis. The objective of this study was to conduct an image analysis and quantitative assessment of the contour of the sagittal section of the left lobe of the liver. Methods: Between February and October 2020, 486 consecutive outpatients underwent ultrasound examinations at our hospital. A total of 214 images were manually annotated by delineating the liver contour to create annotation images. U-Net was employed for liver segmentation, with the dataset divided into training (n = 128), testing (n = 42), and validation (n = 44) subsets. Additionally, 43 Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) cases with pathology data from between 2015 and 2020 were included. Segmentation was performed using the program developed in the first step. Subsequently, shape analysis was conducted using ImageJ. Results: Liver segmentation exhibited high accuracy, as indicated by Dice loss of 0.044, Intersection over Union of 0.935, and an F score of 0.966. The accuracy of the classification of the liver surface as smooth or rough via ResNet 50 was 84.6%. Image analysis showed MinFeret and Minor correlated with liver fibrosis stage (p = 0.046, 0.036, respectively). Sensitivity, specificity, and AUROC of Minor for ≥F3 were 0.571, 0.862, and 0.722, respectively, and F4 were 1, 0.600, and 0.825, respectively. Conclusion: Deep learning segmentation of the sagittal cross-sectional contour of the left lobe of the liver demonstrated commendable accuracy. The roughness of the liver surface was correctly judged by artificial intelligence. Image analysis showed the thickness of the left lobe inversely correlated with liver fibrosis stage. Full article
Show Figures

Figure 1

Figure 1
<p>U-Net architecture.</p>
Full article ">Figure 2
<p>Procedure of annotation, deep learning, and automated segmentation. Annotation was performed manually. Annotation area was demonstrated as a green area. Then, the U-Net model learned these images and generated segmentation images.</p>
Full article ">Figure 3
<p>Represented cases of segmentation of the left liver lobe. (<b>A</b>–<b>C</b>) are original B-mode images. (<b>D</b>–<b>F</b>) are generated with segmentation by AI.</p>
Full article ">Figure 4
<p>Workflow of classification via deep learning.</p>
Full article ">Figure 5
<p>(<b>a</b>) Segmentation image. (<b>b</b>) Result after applying image process. (<b>c</b>) Results after applying affine transformation.</p>
Full article ">Figure 6
<p>The features analyzed with ImageJ.</p>
Full article ">Figure 7
<p>MinFeret and Minor inversely correlated with liver fibrosis stage (<span class="html-italic">p</span> = 0.046 and 0.036, respectively). The circle in F1 meant a maximum value at the box plot.</p>
Full article ">Figure 8
<p>Representative cases. (<b>A</b>,<b>C</b>) are original images, and (<b>B</b>,<b>D</b>) are auto generated segmentation images. (<b>A</b>,<b>C</b>). Liver biopsy showed F1, and Minor was 198.4 in image analysis. (<b>B</b>,<b>D</b>). Liver biopsy showed F4, and Minor was 89.6 in image analysis.</p>
Full article ">
15 pages, 3122 KiB  
Article
Fe3O4@SiO2-NH2 Functionalized Nanoparticles as a Potential Contrast Agent in Magnetic Resonance
by Brayan Stick Betin Bohorquez, Indry Milena Saavedra Gaona, Carlos Arturo Parra Vargas, Karina Vargas-Sánchez, Jahaziel Amaya, Mónica Losada-Barragán, Javier Rincón and Daniel Llamosa Pérez
Condens. Matter 2024, 9(4), 49; https://doi.org/10.3390/condmat9040049 - 17 Nov 2024
Viewed by 485
Abstract
The present work proposes a method for the synthesis of a nanoparticle with a superparamagnetic Fe3O4 core coated with SiO2-NH2 by ultrasound-assisted coprecipitation. Additionally, the nanoparticle is functionalized with a microinflammation biomarker peptide, and its effects on [...] Read more.
The present work proposes a method for the synthesis of a nanoparticle with a superparamagnetic Fe3O4 core coated with SiO2-NH2 by ultrasound-assisted coprecipitation. Additionally, the nanoparticle is functionalized with a microinflammation biomarker peptide, and its effects on the viability of monkey kidney endothelial cells and the Vero cell line were evaluated. The main physicochemical properties of the nanoparticles were characterized by X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), thermogravimetric analysis (TGA), a vibrating sample magnetometer (VSM), a field emission scanning electron, Scanning Electron Microscopy (SEM), and High-Resolution Transmission Electron Microscopy (HR-TEM). The results showed that the nanoparticles are spherical, with sizes smaller than 10 nm, with high thermal stability and superparamagnetic properties. They also demonstrated cell viability rates exceeding 85% through Magnetic Resonance Imaging (MRI). The results indicate the potential of these nanoparticles to be used as a contrast agent in magnetic resonance to detect mild brain lesions. Full article
Show Figures

Figure 1

Figure 1
<p>XRD of Fe<sub>3</sub>O<sub>4</sub> nanoparticles (black) and SiO<sub>2</sub>-NH<sub>2</sub>-coated Fe<sub>3</sub>O<sub>4</sub> nanoparticles (red).</p>
Full article ">Figure 2
<p>FITR of Fe<sub>3</sub>O<sub>4</sub> and Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>-NH<sub>2</sub> nanoparticles.</p>
Full article ">Figure 3
<p>DSC-TGA of Fe<sub>3</sub>O<sub>4</sub> (<b>a</b>) and (<b>b</b>) Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>-NH<sub>2</sub> nanoparticles.</p>
Full article ">Figure 4
<p>Magnetic characterization curves of Fe<sub>3</sub>O<sub>4</sub> (<b>a</b>) and (<b>b</b>) Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>-NH<sub>2</sub> nanoparticles.</p>
Full article ">Figure 5
<p>TEM of Fe<sub>3</sub>O<sub>4</sub> (<b>a</b>), SiO<sub>2</sub>-NH<sub>2</sub>-coated Fe<sub>3</sub>O<sub>4</sub> nanoparticles (<b>b</b>), and Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>-NH<sub>2</sub>/P-88 (<b>c</b>) nanoparticles, together with the corresponding nanoparticle size distributions.</p>
Full article ">Figure 6
<p>HRTEM of Fe<sub>3</sub>O<sub>4</sub> nanoparticles (<b>a</b>), fast Fourier transform of Fe<sub>3</sub>O<sub>4</sub> nanoparticles (<b>b</b>), and simulation of the crystalline structure of Fe<sub>3</sub>O<sub>4</sub> nanoparticles verified through open access database The Materials Project (<b>c</b>).</p>
Full article ">Figure 7
<p>(<b>a</b>) Verification of the anchorage of P-88 on the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>-NH<sub>2</sub> nanoparticle using a biotin-streptavidin-HRP assay (Student’s test n:3 * <span class="html-italic">p</span> &lt; 0.05). (<b>b</b>) Cell viability assays of Fe<sub>3</sub>O<sub>4</sub>, Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>-NH<sub>2</sub>, and Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>-NH<sub>2</sub>/P-88 nanoparticles (* <span class="html-italic">p</span> &lt; 0.05, and **** <span class="html-italic">p</span> &lt; 0.0001).</p>
Full article ">
7 pages, 1589 KiB  
Case Report
Spontaneous Postoperative Reduction of Ulnar Aneurism by Simple Decompression of Guyon’s Canal in a Patient with Hypothenar Hammer Syndrome: A Case Report
by Ettore Gasparo, Adrian Gustar, Matteo Atzeni, Pietro Luciano Serra and Filippo Boriani
Reports 2024, 7(4), 101; https://doi.org/10.3390/reports7040101 - 17 Nov 2024
Viewed by 222
Abstract
Background: Guyon’s canal syndrome is a pathological condition caused by compression of the ulnar nerve at the level of the wrist. It is less frequent than other compression syndromes of the upper limb (cubital and carpal tunnel), and different causative agents, including vascular [...] Read more.
Background: Guyon’s canal syndrome is a pathological condition caused by compression of the ulnar nerve at the level of the wrist. It is less frequent than other compression syndromes of the upper limb (cubital and carpal tunnel), and different causative agents, including vascular lesions, are described. Among these, aneurysm of the ulnar artery is described in the literature as an infrequent aetiology. Case Presentation: We report the case of a 25-year-old young man with Guyon’s canal syndrome caused by an aneurysm of the ulnar artery, who underwent surgical decompression of the Guyon’s canal without intervening on the aneurysm. The postoperative course was free of complications, and the patient reported satisfaction, with reduced symptoms. Clinical examination and ultrasound imaging showed mass reduction of the aneurysm in the postoperative period, which appears to be an evolution hitherto undocumented in the literature. Conclusions: Many treatments are available for Guyon’s canal syndrome. Past medical and surgical treatments, duration and severity of symptoms, causes, and pathogenesis are important for therapeutic choice. Surgical treatment based on ligament section and lysis of the Guyon’s canal downstream, without any action on the aneurysm and with ulnar artery preservation, determined a reduction in terms of volume, relief of the symptoms, and patient satisfaction. With this case we describe a surgical therapeutic option for the treatment of Guyon’s canal syndrome caused by an aneurysm of the ulnar artery, in which surgery is limited to canal decompression and consequential aneurism mass reduction with concomitant relief of symptoms. Full article
(This article belongs to the Section Surgery)
Show Figures

Figure 1

Figure 1
<p>Preoperative ultrasonography; D1 shows the length of ulnar artery aneurysm (19 mm).</p>
Full article ">Figure 2
<p>Intraoperatory view; the aneurysm of the ulnar artery was identified. Dissection of the subcutaneous planes to expose the ulnar nerve while preserving the ulnar nerve integrity. Complete section of the volar carpal ligament and the most distal segment of the piso-hamate ligament.</p>
Full article ">Figure 3
<p>Two-month postoperative ultrasonography shows a reduction of ulnar artery aneurysm from 19 mm to 16.3 mm.</p>
Full article ">Figure 4
<p>Three-month postoperative ultrasonography shows a reduction of ulnar artery aneurysm from 16.3 mm to 16.0 mm.</p>
Full article ">
15 pages, 3218 KiB  
Article
Relationship Between Ultrasound Diagnosis, Symptoms and Pain Scale Score on Examination in Patients with Uterosacral Ligament Endometriosis
by Shae Maple, Eva Bezak, K. Jane Chalmers and Nayana Parange
J. Clin. Med. 2024, 13(22), 6901; https://doi.org/10.3390/jcm13226901 - 16 Nov 2024
Viewed by 332
Abstract
Background/Objectives: This study investigated patient pain descriptors for transvaginal ultrasound (TVS) diagnostic evaluation of endometriosis for uterosacral ligaments (USLs), including correlation between USL thickness and site-specific tenderness (SST). It further investigated if SST could positively assist diagnosing endometriosis on TVS. Methods: TVS images [...] Read more.
Background/Objectives: This study investigated patient pain descriptors for transvaginal ultrasound (TVS) diagnostic evaluation of endometriosis for uterosacral ligaments (USLs), including correlation between USL thickness and site-specific tenderness (SST). It further investigated if SST could positively assist diagnosing endometriosis on TVS. Methods: TVS images and SST pain descriptors were collected from 42 patients. SST was evaluated by applying sonopalpation during TVS. The images were presented to six observers for diagnosis based on established USL criteria. Following this, they were given the SST pain scores and asked to reevaluate their diagnosis to assess if the pain scores impacted their decision. Results: An independent t-test showed that the patients with an endometriosis history had higher pain scores overall (7.2 ± 0.59) compared to the patients with no history (0.34 ± 0.12), t (40) = 8.8673. Spearman’s correlation showed a strong correlation to the pain scale score for clinical symptoms (r = 0.74), endometriosis diagnosis (r = 0.78), USL thickness (r = 0.74), and when USL nodules were identified (r = 0.70). Paired t-tests showed that the observers demonstrated a higher ability to correctly identify endometriosis with the pain scale information (33 ± 8.83) as opposed to not having this information (29.67 ± 6.31), which was a statistically significant change of 3.33, t (5) = 2.7735. Conclusions: Patients with an endometriosis history have significantly higher pain scores on TVS compared to patients with no endometriosis history. A strong correlation was shown between SST pain scores and patient symptoms, USL thickness, and USL nodules. Inclusion of SST alongside TVS imaging shows promise, with these results demonstrating a higher ability to diagnose endometriosis with additional SST pain scale information. Full article
Show Figures

Figure 1

Figure 1
<p>Flowchart summarizing the methodology process and the inclusion criteria of eligible patients and observers in the study. TVS, transvaginal ultrasound, DE, Deep Endometriosis, IDEA, International Deep Endometriosis Analysis, SST, site-specific tenderness.</p>
Full article ">Figure 2
<p>Whisker plots demonstrating the Spearman’s correlation coefficient results for endometriosis characteristics versus pain scale. These graphs show the spread of endometriosis characteristics with patient SST pain scores on TVS (where X = mean score) with statistical significance (where all <span class="html-italic">p</span> &lt; 0.0005), as represented in <a href="#jcm-13-06901-t003" class="html-table">Table 3</a>. (<b>A</b>) Correlation of endometriosis diagnosis (surgically or clinically by referring gynecologist) and pain; (<b>B</b>) correlation of patient clinical symptoms (chronic pelvic pain, dysmenorrhea, and dyspareunia) and pain; (<b>C</b>) correlation of USL thickness and pain; and (<b>D</b>) correlation of USL nodules (endometriosis identified including a focal USL nodule and endometriosis identified with no USL nodule seen) and pain.</p>
Full article ">Figure 3
<p>Graph representation of relationship of diagnostic scores of professional observers before and after using pain scale across the six observers, as shown in <a href="#jcm-13-06901-t004" class="html-table">Table 4</a>.</p>
Full article ">Figure 4
<p>Ultrasound images correlating patient TVS and SST. (<b>A</b>) Endometriomas/medialized ovaries to USLs: Transverse TVS image shows there are bilateral endometriomas and medialization of both ovaries adherent to the USLs (right and left as labeled) at the torus uterinus. A focal endometriotic nodule (arrows) can be seen between the right and left USLs. This patient has confirmed endometriosis associated with long-standing pelvic pain. Correlating SST at this location was described as “sharp” with a total 13/15 pain score. (<b>B</b>) Thickened USL and nodule: USL DE in a woman with severe pelvic pain and dyspareunia who was confirmed to have extensive endometriosis in laparoscopy. Sagittal TVS image shows an irregular and thickened left USL (labeled with caliper measuring 6.5 mm) with adherence of the left ovary (labeled). There is an associated focal endometriotic nodule (arrows) adherent to the adjacent structures. Calipers demonstrate a 6.5 mm thickness of the left USL measured at the thickest point. Correlating SST at this location was described as “sharp” with a total 12/15 pain score. (<b>C</b>) Rectosigmoid DE adherent to USL: Sagittal TVS image demonstrating extensive deep infiltrative endometriosis. Endometriosis plaque deposits (circled) can be seen at the level of the rectosigmoid bowel, tethered to the inferior margin of the left ovary (labeled). The left ovary is medialized, with an endometrioma adherent to the torus uterinus, extending to the right USL. Correlating SST at this location was described as “sharp” with a total 10/15 pain score.</p>
Full article ">
14 pages, 442 KiB  
Article
Quantitative Approach to Quality Review of Prenatal Ultrasound Examinations: Estimated Fetal Weight and Fetal Sex
by C. Andrew Combs, Ryan C. Lee, Sarah Y. Lee, Sushma Amara and Olaide Ashimi Balogun
J. Clin. Med. 2024, 13(22), 6895; https://doi.org/10.3390/jcm13226895 - 16 Nov 2024
Viewed by 250
Abstract
Background/Objectives: Systematic quality review of ultrasound exams is recommended to ensure accurate diagnosis. Our primary objectives were to develop a quantitative method for quality review of estimated fetal weight (EFW) and to assess the accuracy of EFW for an entire practice and [...] Read more.
Background/Objectives: Systematic quality review of ultrasound exams is recommended to ensure accurate diagnosis. Our primary objectives were to develop a quantitative method for quality review of estimated fetal weight (EFW) and to assess the accuracy of EFW for an entire practice and for individual personnel. A secondary objective was to evaluate the accuracy of fetal sex determination. Methods: This is a retrospective cohort study. Eligible ultrasound exams included singleton pregnancies with live birth and known birth weight (BW). A published method was used to predict BW from EFW for exams with ultrasound-to-delivery intervals of up to 12 weeks. Mean error and median absolute error (AE) were compared between different personnel. Image audits were performed for exams with AE > 30% and exams with reported fetal sex different than newborn sex. Results: We analyzed 1938 exams from 890 patients. In the last exam before birth, the median AE was 5.9%, and the predicted BW was within ±20% of the actual BW in 97.2% of patients. AE was >30% in 28 exams (1.4%); image audit found correct caliper placement in all 28. Only two patients (0.2%) had AE > 30% on the last exam before birth. One sonographer systematically over-measured head and abdominal circumferences, leading to EFWs that were overestimated. Reported fetal sex differed from newborn sex in seven exams (0.4%) and five patients (0.6%). Images in four of these patients were annotated with the correct fetal sex, but a clerical error was made in the report. In one patient, an unclear image was labeled “probably female”, but the newborn was male. Conclusions: The accuracy of EFW in this practice was similar to literature reports. The quantitative analysis identified a sonographer with outlier measurements. Time-consuming image audits could be focused on a small number of exams with large errors. We suggest some enhancements to ultrasound reporting software that may help to reduce clerical errors. We provide tools to help other practices perform similar quality reviews. Full article
(This article belongs to the Special Issue Progress in Patient Safety and Quality in Maternal–Fetal Medicine)
Show Figures

Figure 1

Figure 1
<p>Flow diagram showing numbers of patients, eligible exams, exclusions, and exams included in the final analysis. Abbreviations: GSH—Good Samaritan Hospital. US—ultrasound.</p>
Full article ">
17 pages, 6219 KiB  
Article
DGGNets: Deep Gradient-Guidance Networks for Speckle Noise Reduction
by Li Wang, Jinkai Li, Yi-Fei Pu, Hao Yin and Paul Liu
Fractal Fract. 2024, 8(11), 666; https://doi.org/10.3390/fractalfract8110666 - 15 Nov 2024
Viewed by 234
Abstract
Speckle noise is a granular interference that degrades image quality in coherent imaging systems, including underwater sonar, Synthetic Aperture Radar (SAR), and medical ultrasound. This study aims to enhance speckle noise reduction through advanced deep learning techniques. We introduce the Deep Gradient-Guidance Network [...] Read more.
Speckle noise is a granular interference that degrades image quality in coherent imaging systems, including underwater sonar, Synthetic Aperture Radar (SAR), and medical ultrasound. This study aims to enhance speckle noise reduction through advanced deep learning techniques. We introduce the Deep Gradient-Guidance Network (DGGNet), which features an architecture comprising one encoder and two decoders—one dedicated to image recovery and the other to gradient preservation. Our approach integrates a gradient map and fractional-order total variation into the loss function to guide training. The gradient map provides structural guidance for edge preservation and directs the denoising branch to focus on sharp regions, thereby preventing over-smoothing. The fractional-order total variation mitigates detail ambiguity and excessive smoothing, ensuring rich textures and detailed information are retained. Extensive experiments yield an average Peak Signal-to-Noise Ratio (PSNR) of 31.52 dB and a Structural Similarity Index (SSIM) of 0.863 across various benchmark datasets, including McMaster, Kodak24, BSD68, Set12, and Urban100. DGGNet outperforms existing methods, such as RIDNet, which achieved a PSNR of 31.42 dB and an SSIM of 0.853, thereby establishing new benchmarks in speckle noise reduction. Full article
Show Figures

Figure 1

Figure 1
<p>System architecture of a speckle noise reduction system.</p>
Full article ">Figure 2
<p>The network structure of the proposed DGGNet. The DGGNet consists of one encoder and two decoders (one decoder works for the denoising branch, and the other works for the gradient branch). The gradient branch guides the denoising branch by fusing gradient information to enhance structure preservation.</p>
Full article ">Figure 3
<p>The flow diagram of the proposed DGGNet.</p>
Full article ">Figure 4
<p>Denoising visualization of our proposed DGGNet comparing competing methods on the ultrasound dataset. From left to right, we show the clean, noisy, and denoising results of SRAD [<a href="#B23-fractalfract-08-00666" class="html-bibr">23</a>], OBNLM [<a href="#B8-fractalfract-08-00666" class="html-bibr">8</a>], NLLRF [<a href="#B7-fractalfract-08-00666" class="html-bibr">7</a>], MHM [<a href="#B35-fractalfract-08-00666" class="html-bibr">35</a>], DnCNN [<a href="#B16-fractalfract-08-00666" class="html-bibr">16</a>], RIDNet [<a href="#B17-fractalfract-08-00666" class="html-bibr">17</a>], MSANN [<a href="#B20-fractalfract-08-00666" class="html-bibr">20</a>] and our proposed DGGNet.</p>
Full article ">Figure 5
<p>Denoising visualization of our proposed DGGNet comparing competing methods on the ultrasound dataset. From left to right, we show the ground truth, noisy, and denoising results of SRAD [<a href="#B23-fractalfract-08-00666" class="html-bibr">23</a>], OBNLM [<a href="#B8-fractalfract-08-00666" class="html-bibr">8</a>], NLLRF [<a href="#B7-fractalfract-08-00666" class="html-bibr">7</a>], DnCNN [<a href="#B16-fractalfract-08-00666" class="html-bibr">16</a>], MHM [<a href="#B35-fractalfract-08-00666" class="html-bibr">35</a>], RIDNet [<a href="#B17-fractalfract-08-00666" class="html-bibr">17</a>], MSANN [<a href="#B20-fractalfract-08-00666" class="html-bibr">20</a>], and our DGGNet.</p>
Full article ">Figure 6
<p>Denoising visualization of our proposed DGGNet compares competing methods on the realistic experiments data. From left to right, we show the noisy, denoising results of SRAD [<a href="#B23-fractalfract-08-00666" class="html-bibr">23</a>], OBNLM [<a href="#B8-fractalfract-08-00666" class="html-bibr">8</a>], NLLRF [<a href="#B7-fractalfract-08-00666" class="html-bibr">7</a>], MHM [<a href="#B35-fractalfract-08-00666" class="html-bibr">35</a>], DnCNN [<a href="#B16-fractalfract-08-00666" class="html-bibr">16</a>], RIDNet [<a href="#B17-fractalfract-08-00666" class="html-bibr">17</a>], MSANN [<a href="#B20-fractalfract-08-00666" class="html-bibr">20</a>] and our proposed DGGNet.</p>
Full article ">Figure 7
<p>Average feature maps of results of the upsampling block in the decoding architecture of the denoising branch in our proposed DGGNet. The top image in (<b>a</b>) is our denoising result, and the bottom image is the corresponding noisy image. (<b>b</b>–<b>e</b>) are the average feature maps of <math display="inline"><semantics> <mrow> <mn>16</mn> <mo>×</mo> <mn>16</mn> </mrow> </semantics></math>, <math display="inline"><semantics> <mrow> <mn>32</mn> <mo>×</mo> <mn>32</mn> </mrow> </semantics></math>, <math display="inline"><semantics> <mrow> <mn>64</mn> <mo>×</mo> <mn>64</mn> </mrow> </semantics></math>, and <math display="inline"><semantics> <mrow> <mn>128</mn> <mo>×</mo> <mn>128</mn> </mrow> </semantics></math> in the denoising branch of the decoding structure. The upper images of those image pairs are the average feature map of the denoising branch with the gradient branch, while the lower images are not. This shows that with the guide of the gradient branch in our DGGNet, the denoising result can preserve structure information better.</p>
Full article ">
8 pages, 1929 KiB  
Protocol
Long Term Follow-Up in Gluteal Augmentation Using Cross-Linked Hyaluronic Acid: Up to 20 Months Ultrasound Follow-Up
by Renato Pazzini, Renata Viana and Giseli Petrone
Cosmetics 2024, 11(6), 194; https://doi.org/10.3390/cosmetics11060194 - 15 Nov 2024
Viewed by 384
Abstract
This article describes a technique for gluteal augmentation using cross-linked hyaluronic acid (HA) filler, with a focus on long-term patient follow-up. The rising demand for buttock enhancement driven by esthetic preferences has led to the exploration of minimally invasive alternatives to traditional surgical [...] Read more.
This article describes a technique for gluteal augmentation using cross-linked hyaluronic acid (HA) filler, with a focus on long-term patient follow-up. The rising demand for buttock enhancement driven by esthetic preferences has led to the exploration of minimally invasive alternatives to traditional surgical methods. Ultrasound imaging was utilised to evaluate the presence and distribution of HA filler over time. The patients reported satisfactory aesthetic improvements, with mild transient side effects. The findings highlight the technique’s effectiveness in achieving enhanced gluteal contour with a minimal volume of filler, demonstrating both safety and durability in the long term. This innovative approach may serve as a valuable option in aesthetic practises focused on body contouring. Full article
Show Figures

Figure 1

Figure 1
<p>(<b>A</b>) on the right, pre-procedure marking of the buttocks showing the six gluteal areas (B1–B6) where injections should be applied. IB1 and IB2 are the danger zones. On the left, the suggested filler quantities. (<b>B</b>) Lateral view of the marking showing hip-dip area (B6).</p>
Full article ">Figure 2
<p>Multifrequency ultrasound image showing hyaluronic acid pockets in the buttocks at 12-month (<b>A</b>) and 20-month (<b>B</b>,<b>C</b>) imaging follow-ups.</p>
Full article ">Figure 3
<p>(<b>A</b>) Pre-procedure clinical picture. (<b>B</b>) Immediate post-procedure picture.</p>
Full article ">Figure 4
<p>(<b>A</b>) Pre-procedure clinical picture. (<b>B</b>) Immediate post-procedure picture. (<b>C</b>) The 6-month follow-up clinical picture.</p>
Full article ">Figure 5
<p>(<b>A</b>) Pre-procedure clinical picture. (<b>B</b>) Six-month follow-up clinical picture.</p>
Full article ">
10 pages, 2301 KiB  
Article
Clinically Significant Prostate Cancer Prediction Using Multimodal Deep Learning with Prostate-Specific Antigen Restriction
by Hayato Takeda, Jun Akatsuka, Tomonari Kiriyama, Yuka Toyama, Yasushi Numata, Hiromu Morikawa, Kotaro Tsutsumi, Mami Takadate, Hiroya Hasegawa, Hikaru Mikami, Kotaro Obayashi, Yuki Endo, Takayuki Takahashi, Manabu Fukumoto, Ryuji Ohashi, Akira Shimizu, Go Kimura, Yukihiro Kondo and Yoichiro Yamamoto
Curr. Oncol. 2024, 31(11), 7180-7189; https://doi.org/10.3390/curroncol31110530 - 15 Nov 2024
Viewed by 326
Abstract
Prostate cancer (PCa) is a clinically heterogeneous disease. Predicting clinically significant PCa with low–intermediate prostate-specific antigen (PSA), which often includes aggressive cancers, is imperative. This study evaluated the predictive accuracy of deep learning analysis using multimodal medical data focused on clinically significant PCa [...] Read more.
Prostate cancer (PCa) is a clinically heterogeneous disease. Predicting clinically significant PCa with low–intermediate prostate-specific antigen (PSA), which often includes aggressive cancers, is imperative. This study evaluated the predictive accuracy of deep learning analysis using multimodal medical data focused on clinically significant PCa in patients with PSA ≤ 20 ng/mL. Our cohort study included 178 consecutive patients who underwent ultrasound-guided prostate biopsy. Deep learning analyses were applied to predict clinically significant PCa. We generated receiver operating characteristic curves and calculated the corresponding area under the curve (AUC) to assess the prediction. The AUC of the integrated medical data using our multimodal deep learning approach was 0.878 (95% confidence interval [CI]: 0.772–0.984) in all patients without PSA restriction. Despite the reduced predictive ability of PSA when restricted to PSA ≤ 20 ng/mL (n = 122), the AUC was 0.862 (95% CI: 0.723–1.000), complemented by imaging data. In addition, we assessed clinical presentations and images belonging to representative false-negative and false-positive cases. Our multimodal deep learning approach assists physicians in determining treatment strategies by predicting clinically significant PCa in patients with PSA ≤ 20 ng/mL before biopsy, contributing to personalized medical workflows for PCa management. Full article
(This article belongs to the Special Issue New Aspects in Prostate Cancer Imaging)
Show Figures

Figure 1

Figure 1
<p>Flowchart of the patient selection procedure.</p>
Full article ">Figure 2
<p>Graphical flowchart of machine learning analysis. Step 1: individual medical data analysis (upper image)—our system selected three images (yellow frame) of each modality based on the method in <a href="#sec2dot5-curroncol-31-00530" class="html-sec">Section 2.5</a> (automated selection). Predictive probabilities belonging to each of the three images outputted by neural network are employed as SVM features for prediction. Step 2: integrated analysis (lower image)—similarly, our system selected three images (yellow frame) belonging to each modality based on the method in <a href="#sec2dot5-curroncol-31-00530" class="html-sec">Section 2.5</a> (automated selection). A total of 12 predictive probabilities from each modality along with clinical data (PSA) were employed as SVM features for prediction. Abbreviations: SVM: support vector machine, PSA: prostate-specific antigen, T2WI: T2-weighted imaging, ADC: apparent diffusion coefficient, DWI: diffusion-weighted imaging.</p>
Full article ">Figure 3
<p>ROC curves of clinically significant PCa prediction using routine clinical data. (<b>a</b>) Ultrasound image, (<b>b</b>) T2WI, (<b>c</b>) DWI, (<b>d</b>) ADC, (<b>e</b>) integrated medical data. The blue line represents the ROC curve for the PSA level, while the red line corresponds to the ROC curve for each dataset. The blue-shaded region indicates the 95% CI for PSA, and the red-shaded regions represent the 95% CIs for each dataset. We determined the thresholds using the Youden index.</p>
Full article ">Figure 4
<p>ROC curves for clinically significant PCa prediction in patients with PSA &lt; 20 ng/mL using routine clinical data. (<b>a</b>) Ultrasound image, (<b>b</b>) T2WI, (<b>c</b>) DWI, (<b>d</b>) ADC, (<b>e</b>) integrated medical data. The blue line represents the ROC curve for the PSA level, whereas the red line corresponds to the ROC curve for each dataset. The blue-shaded region indicates the 95% CI for PSA, and the red-shaded regions represent the 95% CIs for each dataset. We determined the thresholds using the Youden index.</p>
Full article ">
13 pages, 4708 KiB  
Article
Reduction in Synovitis Following Genicular Artery Embolization in Knee Osteoarthritis: A Prospective Ultrasound and MRI Study
by Louise Hindsø, Per Hölmich, Michael M. Petersen, Jack J. Xu, Søren Heerwagen, Michael B. Nielsen, Robert G. C. Riis, Adam E. Hansen, Lene Terslev, Mikkel Taudorf and Lars Lönn
Diagnostics 2024, 14(22), 2564; https://doi.org/10.3390/diagnostics14222564 - 15 Nov 2024
Viewed by 475
Abstract
Background/Objectives: Genicular artery embolization (GAE) has demonstrated potential as a treatment for knee osteoarthritis by targeting inflammation and pain, although current evidence remains limited. This study used imaging biomarkers to objectively assess synovitis and possible ischemic complications following GAE. Methods: This was a [...] Read more.
Background/Objectives: Genicular artery embolization (GAE) has demonstrated potential as a treatment for knee osteoarthritis by targeting inflammation and pain, although current evidence remains limited. This study used imaging biomarkers to objectively assess synovitis and possible ischemic complications following GAE. Methods: This was a prospective, single-center trial including participants with mild-to-moderate knee osteoarthritis. Ultrasound, contrast-enhanced (CE), and non-CE-MRI were performed two days before and one and six months after GAE. Ultrasound biomarkers included synovial hypertrophy, effusion, and Doppler activity. A combined effusion-synovitis score was assessed on non-CE-MRI, while CE-MRI allowed differentiation between synovium and effusion and was used to calculate whole-joint and local synovitis scores. The post-GAE MRIs were reviewed for ischemic complications. Results: Seventeen participants (aged 43–71) were treated. Significant reductions were observed in ultrasound-assessed synovial hypertrophy and Doppler activity, as well as in CE-MRI local and whole-joint synovitis scores. While reductions in effusion were noted in both ultrasound and MRI, these changes did not reach statistical significance. At one month, MRI revealed three cases of nonspecific osteonecrosis-like areas, which resolved completely by six months. Conclusions: This study demonstrated a reduction in synovitis and no permanent ischemic complication following GAE in knee osteoarthritis. Larger studies with longer follow-up are needed to confirm the long-term efficacy and safety of the procedure. Full article
(This article belongs to the Special Issue Novel Technologies in Orthopedic Surgery: Diagnosis and Management)
Show Figures

Figure 1

Figure 1
<p>Ultrasound biomarkers of synovitis: (<b>a</b>) suprapatellar recess with severe synovial hypertrophy (arrow); (<b>b</b>) suprapatellar recess with major effusion (cross); (<b>c</b>) lateral parapatellar recess with severe Doppler activity (color) and a moderate osteophyte (arrow); (<b>d</b>) Baker’s cyst (arrows) with synovial hypertrophy.</p>
Full article ">Figure 2
<p>CE-MRI at baseline and 6 months post-GAE. On axial CE-MRI, the synovial thickness of the medial (white arrow) and lateral parapatellar (grey arrow) areas, as well as a possible Baker’s cyst (dotted circle), were included in the whole-joint synovitis score along with areas scored at sagittal images. This patient, treated on the medial side of the left knee, showed a reduction in both local and whole-joint synovitis scores 6 months post-GAE (<b>b</b>) compared to baseline (<b>a</b>).</p>
Full article ">Figure 3
<p>Ultrasound biomarkers of synovitis before and after GAE in the treated areas. Each line represents one participant. <span class="html-italic">n</span> = 17. (<b>a</b>,<b>b</b>): The ultrasound score in the parapatellar recess corresponding to the treated area was used. If both the medial and lateral sides were treated, the highest score was recorded. (<b>c</b>): Effusion was assessed across all three recesses.</p>
Full article ">Figure 4
<p>MRI biomarkers of synovitis before and after GAE. Each line represents one participant. <span class="html-italic">n</span> = 17. (<b>a</b>) MOAKS (MRI Osteoarthritis Knee Score; [<a href="#B33-diagnostics-14-02564" class="html-bibr">33</a>]) from grade 0 to 3, best to worst. (<b>b</b>) Guermazi [<a href="#B20-diagnostics-14-02564" class="html-bibr">20</a>] whole-joint synovitis score from 0 to 22, best to worst. (<b>c</b>) The local synovitis score is a derived Guermazi score only including treated areas (parameniscal and parapatellar) and ranging from 0 to 8 (0 to 4 for participants only treated at one site of the knee), best to worst.</p>
Full article ">Figure 5
<p>Ischemic-like lesions on MRI. Three cases of nonspecific ischemic-like lesions one month after GAE (white arrows), all completely resolved by six months. The three participants were embolized in the following areas: (<b>a</b>) medial side of the right knee, (<b>b</b>) medial and lateral side of the right knee, and (<b>c</b>) medial side of the left knee. In all three cases, the lesions corresponded to the treated areas.</p>
Full article ">
16 pages, 9423 KiB  
Article
EchoPT: A Pretrained Transformer Architecture That Predicts 2D In-Air Sonar Images for Mobile Robotics
by Jan Steckel, Wouter Jansen and Nico Huebel
Biomimetics 2024, 9(11), 695; https://doi.org/10.3390/biomimetics9110695 - 13 Nov 2024
Viewed by 433
Abstract
The predictive brain hypothesis suggests that perception can be interpreted as the process of minimizing the error between predicted perception tokens generated via an internal world model and actual sensory input tokens. When implementing working examples of this hypothesis in the context of [...] Read more.
The predictive brain hypothesis suggests that perception can be interpreted as the process of minimizing the error between predicted perception tokens generated via an internal world model and actual sensory input tokens. When implementing working examples of this hypothesis in the context of in-air sonar, significant difficulties arise due to the sparse nature of the reflection model that governs ultrasonic sensing. Despite these challenges, creating consistent world models using sonar data is crucial for implementing predictive processing of ultrasound data in robotics. In an effort to enable robust robot behavior using ultrasound as the sole exteroceptive sensor modality, this paper introduces EchoPT (Echo-Predicting Pretrained Transformer), a pretrained transformer architecture designed to predict 2D sonar images from previous sensory data and robot ego-motion information. We detail the transformer architecture that drives EchoPT and compare the performance of our model to several state-of-the-art techniques. In addition to presenting and evaluating our EchoPT model, we demonstrate the effectiveness of this predictive perception approach in two robotic tasks. Full article
(This article belongs to the Special Issue Artificial Intelligence for Autonomous Robots: 3rd Edition)
Show Figures

Figure 1

Figure 1
<p>Overview of the experimental setup. Panel (<b>a</b>) shows the simulation environment in which a two-wheeled robot drives. A sketch of the robot is shown in panel (<b>c</b>). The robot uses an array-based imaging sonar sensor panel (<b>g</b>) capable of generating range-direction energy maps (called energyscapes), shown in panels (<b>d</b>–<b>f</b>). This sensor is modeled in the simulation environment based on accurate models of acoustic propagation and reflection. Panel (<b>b</b>) shows what is called the acoustic flow model. This model predicts how objects in the sensor scene move through the perceptive field based on a certain robot motion. The blue flow lines are shown for a linear robot motion. Panels (<b>d</b>–<b>f</b>) show the task that is being solved in this paper: how can novel sensor views be synthesized given a certain set of robot velocity commands <math display="inline"><semantics> <mfenced open="[" close="]"> <mtable> <mtr> <mtd> <msub> <mi>v</mi> <mrow> <mi>l</mi> <mi>i</mi> <mi>n</mi> </mrow> </msub> </mtd> <mtd> <msub> <mi>ω</mi> <mi>r</mi> </msub> </mtd> </mtr> </mtable> </mfenced> </semantics></math>? Each of these velocities has a time-step index, as shown in panels (<b>d</b>–<b>f</b>). Panel (<b>d</b>) shows the prediction based on the naive shifting of the image in the range and direction dimensions. Panel (<b>e</b>) shows the operation using the acoustic flow model of panel (<b>b</b>). Both of these operators can only use the last frame to perform the prediction. Panel (<b>f</b>) shows the EchoPT model, which takes in <span class="html-italic">n</span> previous frames and velocity commands and predicts the novel view using a transformer neural network.</p>
Full article ">Figure 2
<p>Overview of the network architecture of EchoPT. The EchoPT model has two inputs: the set of <span class="html-italic">n</span> previous input frames (set to three in this paper) and the <math display="inline"><semantics> <mrow> <mi>n</mi> <mo>+</mo> <mn>1</mn> </mrow> </semantics></math> velocity commands (three previous and one for the prediction). The model has three main parallel branches: a transformer branch, a feed-forward convolutional branch for the sonar images, and an MLP (multi-layer perceptron) pipeline using the velocity commands as input. These three branches are depth-concatenated and passed through more feed-forward convolutional layers to obtain a single output image.</p>
Full article ">Figure 3
<p>Condensed version of <a href="#biomimetics-09-00695-f0A1" class="html-fig">Figure A1</a> in <a href="#app1-biomimetics-09-00695" class="html-app">Appendix A</a>. Panel (<b>a</b>) shows the target sonar image, and panel (<b>b</b>) shows the predicted image. Panel (<b>c</b>) shows the difference between the two images, and panels (<b>d</b>,<b>e</b>) show the 2D correlogram.</p>
Full article ">Figure 4
<p>Prediction results of a single frame using three prediction methods: the naive operation, which shifts the image in the range and direction dimensions; the acoustic flow approach, which uses the acoustic flow equations to transform the image; and finally, the EchoPT prediction.</p>
Full article ">Figure 5
<p>A first application of predictive processing in which a robot performs a trajectory in the environment from <a href="#biomimetics-09-00695-f001" class="html-fig">Figure 1</a>. In two periods (between 10 s and 16 s and between 30 s and 36 s), the robot encounters slip conditions (meaning the robot is not performing the motion that the robot expects to perform). In the first section, the robot is slipping on both wheels; in the second condition, only one wheel slips. The plots show the slip detector, which uses differences in the predicted and measured sensor data for different prediction horizons (one-shot, three-frame auto-regressive, and five-frame auto-regressive). Longer time horizons provide the clearest slip detection signal, with EchoPT being the only one that detects the second slip condition. Panel (<b>a</b>) shows the results for using the naive predictor, panel (<b>b</b>) for the acoustic flow predictor and panel (<b>c</b>) for the EchoPT predictor.</p>
Full article ">Figure 6
<p>A second application of predictive processing in which a robot is tasked with driving from the green rectangular spawn boxes to the waypoint indicated by the green circles, using a subsumption-based control stack described in [<a href="#B13-biomimetics-09-00695" class="html-bibr">13</a>]. Panel (<b>a</b>) shows the kernel density estimate of 50 runs with clean sensor data (signal-to-noise ratio, SNR = 5 dB). In panels (<b>b</b>,<b>c</b>), we added intermittent noise to the measured sensor data (shown in panel f, SNR = −80 dB). In panel (<b>b</b>), the original controller was used, showing the traversed paths’ deterioration. In panel (<b>c</b>), sensor data were predicted in an auto-regressive manner using EchoPT for the duration of the noise bursts and fed into the controller instead of the noisy data. Panel (<b>d</b>) shows the travel time for the robot in the three conditions, showing a large increase in travel time for the controller from panel (<b>b</b>). Panel (<b>e</b>) shows the deviation from the midline of the corridor, again showing a large deviation when no predictive processing is used. Panel (<b>f</b>) shows a small section of the evolution of the SNR over time.</p>
Full article ">Figure A1
<p>Detailed overview of some EchoPT predictions. Given a sequence of sonar images, T1 to T4 (panels (<b>a</b>–<b>d</b>)), with a robot performing a linear motion in a corridor, the EchoPT model predicts T4 (predicted) in panel (<b>e</b>). Panels (<b>f</b>–<b>i</b>) show the difference between T4 (predicted) and T1 to T4. These plots show that the model can capture the motion model of the sensor modality, as the errors between T4 and T4 (predicted) are near zero. The differences with the older images clearly show that the robot has learned to incorporate the sensor flow data. Panels (<b>j</b>–<b>n</b>) show the 2D correlograms between the prediction and the input data.</p>
Full article ">Figure A2
<p>Prediction of sonar images using an auto-regressive prediction model for the three prediction systems used in this paper (naive, acoustic flow, and EchoPT). As the robot motions are relatively small, the difference between the images is not clearly visible. In <a href="#biomimetics-09-00695-f0A3" class="html-fig">Figure A3</a>, we show the differences between the subsequent images, as this illustrates much more clearly what the advantage of the EchoPT model is over the other techniques.</p>
Full article ">Figure A3
<p>Prediction errors using an auto-regressive prediction model for the three prediction systems described. The deeper the prediction horizon, the larger the errors in the data predictions get (very noticeable in frame 6). The EchoPT model maintains the smallest prediction errors, indicating the capability of the model to perform predictions over long time horizons. It should be noted that, after frame 3, no measured data are used in EchoPT, but it purely relies on previous predictions to estimate the new data frame.</p>
Full article ">
12 pages, 1647 KiB  
Article
Accuracy of O-RADS System in Differentiating Between Benign and Malignant Adnexal Masses Assessed via External Validation by Inexperienced Gynecologists
by Peeradech Buranaworathitikul, Veera Wisanumahimachai, Natthaphon Phoblap, Yosagorn Porngasemsart, Waranya Rugfoong, Nuttha Yotchana, Pakaporn Uthaichalanont, Thunthida Jiampochaman, Chayanid Kunanukulwatana, Atiphoom Thiamkaew, Suchaya Luewan, Charuwan Tantipalakorn and Theera Tongsong
Cancers 2024, 16(22), 3820; https://doi.org/10.3390/cancers16223820 - 13 Nov 2024
Viewed by 353
Abstract
Objective: To evaluate the accuracy of the O-RADS system in differentiating between benign and malignant adnexal masses, as assessed by inexperienced gynecologists. Methods: Ten gynecologic residents attended a 20 h training course on the O-RADS system conducted by experienced examiners. Following the training, [...] Read more.
Objective: To evaluate the accuracy of the O-RADS system in differentiating between benign and malignant adnexal masses, as assessed by inexperienced gynecologists. Methods: Ten gynecologic residents attended a 20 h training course on the O-RADS system conducted by experienced examiners. Following the training, the residents performed ultrasound examinations on patients admitted with adnexal masses under supervision, recording the data in a database that included videos and still images. The senior author later accessed this ultrasound database and presented the cases offline to ten residents for O-RADS rating, with the raters being blinded to the final diagnosis. The efficacy of the O-RADS system by the residents and inter-observer variability were assessed. Results: A total of 201 adnexal masses meeting the inclusion criteria were evaluated, consisting of 136 (67.7%) benign masses and 65 (32.3%) malignant masses. The diagnostic performance of the O-RADS system showed a sensitivity of 90.8% (95% CI: 82.2–96.2%) and a specificity of 86.8% (95% CI: 80.4–91.8%). Inter-observer variability in scoring was analyzed using multi-rater Fleiss Kappa analysis, yielding Kappa indices of 0.642 (95% CI: 0.641–0.643). The false positive rate was primarily due to the misclassification of solid components in classic benign masses as O-RADS-4 or O-RADS-5. Conclusions: The O-RADS system demonstrates high diagnostic performance in distinguishing benign from malignant adnexal masses, even when used by inexperienced examiners. However, the false positive rate remains relatively high, mainly due to the over-interpretation of solid-appearing components in classic benign lesions. Despite this, inter-observer variability among non-expert raters was substantial. Incorporating O-RADS system training into residency programs is beneficial for inexperienced practitioners. This study could be an educational model for gynecologic residency training for other systems of sonographic features. Full article
(This article belongs to the Special Issue The Role of Medical Imaging in Gynecological Cancer)
Show Figures

Figure 1

Figure 1
<p>O-RADS checklist.</p>
Full article ">Figure 2
<p>Flowchart of patient recruitment for O-RADS rating.</p>
Full article ">Figure 3
<p>ROC curves demonstrating the performance in predicting malignant mass among ten raters The area under the curve values are not significantly different (Z-test, paired samples; all <span class="html-italic">p</span>-values &gt; 0.05).</p>
Full article ">
Back to TopTop